Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03477682
Other study ID # 15-17005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 7, 2017
Est. completion date June 30, 2021

Study information

Verified date September 2021
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized controlled trial designed to analyze the impact of bedrest duration on return to functional independence at discharge following sartorius flap for coverage of vascular reconstruction in the groin.


Description:

This is a pilot prospective study with the purpose of evaluating the impact of bedrest duration on outcomes of groin muscle flaps used for groin coverage in patients undergoing open, infrainguinal vascular surgery. The investigators plan to target all patients undergoing groin muscle flaps for vascular groin coverage at UCSF. All patients undergoing groin flaps will be block randomized into two cohorts: Cohort 1 - one day of bedrest (mobilize on post-op day 2) versus Cohort 2 - 5 days of bedrest (mobilize on post-op day 6). The investigators perform approximately 50 infrainguinal muscle flaps per year. They aim to enroll 30 patients (15 per cohort). Outcome measures include: surgical complication rates (including wound and lymphatic complications, readmissions, and reoperations), physical function, hospital length of stay, venous thromboembolism (VTE), and rates of discharge to a skilled nursing facility. The investigators will also examine the impact of bedrest on patient reported outcomes one month following surgery. Patient outcomes will be followed for 3 months post-operatively.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date June 30, 2021
Est. primary completion date March 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients undergoing muscle flaps following infrainguinal, open vascular surgery. Patients must be ambulatory at baseline. Patients must be able to provide informed consent. Exclusion Criteria: - Patients who are unable to provide informed consent. Patients are non-ambulatory at baseline. Patients' clinical status is not amenable towards early ambulation. Enrollment is at the discretion of the vascular and plastic surgeons. - Bilateral sartorius flaps

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Early ambulation
Patients who are in the experimental arm will have a shorter duration of bedrest restriction following sartorius surgery (1 day) versus the standard group (5 days bedrest).

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

References & Publications (6)

Evans GR, Francel TJ, Manson PN. Vascular prosthetic complications: success of salvage with muscle-flap reconstruction. Plast Reconstr Surg. 1993 Jun;91(7):1294-302. — View Citation

Fischer JP, Mirzabeigi MN, Sieber BA, Nelson JA, Wu LC, Kovach SJ, Low DW, Serletti JM, Kanchwala S. Outcome analysis of 244 consecutive flaps for managing complex groin wounds. J Plast Reconstr Aesthet Surg. 2013 Oct;66(10):1396-404. doi: 10.1016/j.bjps.2013.06.014. Epub 2013 Jul 5. — View Citation

Fischer JP, Nelson JA, Mirzabeigi MN, Wang GJ, Foley PJ 3rd, Wu LC, Woo EY, Kanchwala S. Prophylactic muscle flaps in vascular surgery. J Vasc Surg. 2012 Apr;55(4):1081-6. doi: 10.1016/j.jvs.2011.10.110. Epub 2011 Dec 29. — View Citation

Genc A. Early mobilization of the critically ill patients: towards standardization. Crit Care Med. 2012 Apr;40(4):1346-7. doi: 10.1097/CCM.0b013e31823b8e44. — View Citation

Greenblatt DY, Rajamanickam V, Mell MW. Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg. 2011 Aug;54(2):433-9. doi: 10.1016/j.jvs.2011.01.034. Epub 2011 Mar 31. — View Citation

Perme C, Chandrashekar R. Early mobility and walking program for patients in intensive care units: creating a standard of care. Am J Crit Care. 2009 May;18(3):212-21. doi: 10.4037/ajcc2009598. Epub 2009 Feb 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in AM-PAC Score AMPAC Score measures functional status 1 week
Secondary Wound infection requiring medication Described infection requiring antibiotics only, no surgery 3 months
Secondary Superficial wound dehiscence Dehiscence of superficial layers (skin and subcutaneous tissue) requiring local wound care. Information will be gathered from medical record as charted by provider describing superficial wound dehiscence or via picture in the chart. This means separation at the skin level and may include, epidermis, dermis or subcutaneous fat or all three. 3 months
Secondary Deep wound dehiscence Dehiscence of wound down to fascia, muscle, exposed vessels, requiring surgery. Information will be gathered from medical record as charted by provider or via picture. It will be described as wound dehiscence beyond the subcutaneous tissue down to fascia, muscle or exposed vessel and that required a re-operation by the plastic surgery team. 3 months
Secondary Wound infection requiring surgery Wound infection or abscess requiring surgery (debridement, incision and drainage, exploration) 3 months
Secondary Length of hospital stay Length of hospitalization following surgery, measured in days 2 weeks
Secondary Rehabilitation Type of rehabilitation after surgery (home health, skilled nursing facility, home physical therapy, none) 3 months
Secondary SF36 Score This survey measures quality of life and will be used to examine the impact of bedrest on patient reported quality of life outcomes postoperatively. Total scores range from 0-100 with higher scores indicating a more favorable state. 3 months
Secondary C-reactive protein A measure of nutritional status, measured on first day of mobilization 1 week. Depending on the assigned group, this will be either on postoperative day two or six.
Secondary Albumin A measure of nutritional status, measured on first day of mobilization 1 week. Depending on the assigned group, this will be either on postoperative day two or six.
Secondary Pre-albumin A measure of nutritional status, measured on first day of mobilization 1 week. Depending on the assigned group, this will be either on postoperative day two or six.
See also
  Status Clinical Trial Phase
Completed NCT01698372 - Negative Pressure Dressing After Saphenous Vein Harvest Phase 1
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated NCT03148496 - Tissue Reinforcement of Incisional Closure Among High Risk Patients N/A
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated NCT03269968 - Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery N/A
Active, not recruiting NCT03390764 - Hernia After Colorectal Cancer Surgery N/A
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Completed NCT05142956 - Smoking Increases the Risk of Postoperative Wound Complications: a Propensity Score-matched Cohort Study
Recruiting NCT03527433 - Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques N/A
Terminated NCT02838017 - Tissue Adhesive vs. Sterile Strips After Cesarean Delivery N/A
Not yet recruiting NCT02967627 - VAC Dressings for Colorectal Resections N/A
Completed NCT04735133 - The Effect of Wound Problems Wound Dressing in Patients With Colorectal Cancer Surgery N/A
Completed NCT03942575 - The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy N/A
Not yet recruiting NCT06191159 - Cosmetic Outcome of Electrocautery, Scalpel and PEAK PlasmaBlade for Surgical Breast Incisions N/A
Terminated NCT02355691 - Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty N/A
Completed NCT02128997 - PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population N/A
Completed NCT01977612 - Randomized Clinical Trial of Skin Closure With Staples Versus Suture Phase 2
Completed NCT03061903 - Closed Incision Negative Pressure Therapy vs Standard of Care N/A
Recruiting NCT03948412 - Negative Pressure Wound Therapy (PREVENA) Versus Standard Dressings for Incision Management After Renal Transplant N/A
Not yet recruiting NCT06337292 - Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial Phase 3